Biomarkers for Personalized Neoadjuvant Therapy in Triple-Negative Breast Cancer: Moving Forward

被引：0
|
作者：
Rauch, Gaiane M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Unit 1473, 1515 Holcombe Blvd, Houston, TX 77030 USA
来源：
RADIOLOGY | 2024年 / 312卷 / 03期
关键词：
D O I：
10.1148/radiol.242011
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Personalized differential expression analysis in triple-negative breast cancer
    Cai, Hao
    Chen, Liangbo
    Yang, Shuxin
    Jiang, Ronghong
    Guo, You
    He, Ming
    Luo, Yun
    Hong, Guini
    Li, Hongdong
    Song, Kai
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2024, 23 (04) : 495 - 506
  • [22] Escalation of neoadjuvant therapy in triple-negative breast cancer-balancing effectiveness and toxicities
    Suppan, Christoph
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024, 17 (04) : 251 - 253
  • [23] Effect of pembrolizumab as neoadjuvant therapy in early triple-negative breast cancer: a systematic review
    Sunaryo, R. V.
    Meta, C. P.
    Amelia, Z.
    Harahap, S.
    Briegetta, M.
    Jhoputri, C. F.
    Kurniawan, A.
    Huang, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S1391 - S1392
  • [24] Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients
    Candelaria, Rosalind P.
    Adrada, Beatriz E.
    Hess, Kenneth
    Santiago, Lumarie
    Lane, Deanna L.
    Thompson, Alastair M.
    Moulder, Stacy L.
    Huang, Monica L.
    Arribas, Elsa M.
    Rauch, Gaiane M.
    Leung, Jessica W. T.
    Symmans, W. Fraser
    Valero, Vicente
    Ravenberg, Elizabeth E.
    White, Jason B.
    Yang, Wei Tse
    EUROPEAN JOURNAL OF RADIOLOGY, 2020, 130
  • [25] Triple-negative breast cancer: Neoadjuvant durvalumab improves prognosis
    Kunzell, Judith Lorenz
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (02)
  • [26] Pembrolizumab in the neoadjuvant Treatment of early triple-negative Breast Cancer
    Dierks, Friederike
    Pietsch, Elisabeth
    Dunst, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (09) : 841 - 843
  • [27] Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer
    Denkert, Carsten
    Schneeweiss, Andreas
    Rey, Julia
    Karn, Thomas
    Hattesohl, Akira
    Weber, Karsten E.
    Rachakonda, Sivaramakrishna
    Braun, Michael
    Huober, Jens
    Jank, Paul
    Sinn, Hans-Peter
    Zahm, Dirk-Michael
    Felder, Barbel
    Hanusch, Claus
    Teply-Szymanski, Julia
    Marme, Frederik
    Fehm, Tanja
    Thomalla, Jorg
    V. Sinn, Bruno
    Stiewe, Thorsten
    Marczyk, Michal
    Blohmer, Jens-Uwe
    van Mackelenbergh, Marion
    Schem, Christian
    Staib, Peter
    Link, Theresa
    Muller, Volkmar
    Stickeler, Elmar
    Stover, Daniel G.
    Solbach, Christine
    Metzger-Filho, Otto
    Jackisch, Christian
    Geyer Jr, Charles E.
    Fasching, Peter A.
    Pusztai, Lajos
    Nekljudova, Valentina
    Untch, Michael
    Loibl, Sibylle
    CELL REPORTS MEDICINE, 2024, 5 (11)
  • [28] Controversial issues in the neoadjuvant treatment of triple-negative breast cancer
    Fitzpatrick, Amanda
    Tutt, Andrew
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [29] Neoadjuvant and Adjuvant Chemotherapy Considerations for Triple-Negative Breast Cancer
    Stover, Daniel G.
    Bell, Caitlin F.
    Tolaney, Sara M.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (03) : 6 - 12
  • [30] Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials
    Amos, Keith D.
    Adamo, Barbara
    Anders, Carey K.
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2012, 2012
12345